Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-06
1992-06-30
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514314, H61K 31505, H61K 31435, H61K 3147
Patent
active
051263530
ABSTRACT:
Novel enantiomeric and diasteroisomeric forms of tetrahydropyridines of the formula ##STR1## wherein n.sub.1 is 0 or 2, A is selected from the group consisting of --(CH.sub.2).sub.n2 -- and alkylene substituted with alkyl having a total of 2 to 8 carbon atoms and n.sub.2 is 0 to 5, Z is selected from the group consisting of phenyl, naphthyl, indenyl, heteromonocycle of 5 to 6 ring members and heterobicycle, each optionally substituted with at least one substituent and their non-toxic, pharmaceutically acceptable acid addition salts and quarternary ammonium salts having central analgesic properties as well as diuretic, anti-arrhythmic, anti-cerebral-ischemia and hypotensive properties.
REFERENCES:
patent: 4927832 (1990-05-01), Clemence et al.
Clemence Francois
Fortin Michel
Frechet Daniel
Bernhardt F.
Bond Robert T.
Roussel Uclaf
LandOfFree
Compositions and method of treating arrythmia with tetrahydropyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and method of treating arrythmia with tetrahydropyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and method of treating arrythmia with tetrahydropyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1864038